» Articles » PMID: 32210029

TGF-β Signaling

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Mar 27
PMID 32210029
Citations 307
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-β (TGF-β) represents an evolutionarily conserved family of secreted polypeptide factors that regulate many aspects of physiological embryogenesis and adult tissue homeostasis. The TGF-β family members are also involved in pathophysiological mechanisms that underlie many diseases. Although the family comprises many factors, which exhibit cell type-specific and developmental stage-dependent biological actions, they all signal via conserved signaling pathways. The signaling mechanisms of the TGF-β family are controlled at the extracellular level, where ligand secretion, deposition to the extracellular matrix and activation prior to signaling play important roles. At the plasma membrane level, TGF-βs associate with receptor kinases that mediate phosphorylation-dependent signaling to downstream mediators, mainly the SMAD proteins, and mediate oligomerization-dependent signaling to ubiquitin ligases and intracellular protein kinases. The interplay between SMADs and other signaling proteins mediate regulatory signals that control expression of target genes, RNA processing at multiple levels, mRNA translation and nuclear or cytoplasmic protein regulation. This article emphasizes signaling mechanisms and the importance of biochemical control in executing biological functions by the prototype member of the family, TGF-β.

Citing Articles

A positive feedback loop between SMAD3 and PINK1 in regulation of mitophagy.

Tang M, Rong D, Gao X, Lu G, Tang H, Wang P Cell Discov. 2025; 11(1):22.

PMID: 40064862 PMC: 11894195. DOI: 10.1038/s41421-025-00774-4.


Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?.

van der Mescht M, Steel H, Anderson R, Rossouw T Front Cell Infect Microbiol. 2025; 14:1458195.

PMID: 40008234 PMC: 11850333. DOI: 10.3389/fcimb.2024.1458195.


ActRII or BMPR ligands inhibit skeletal myoblast differentiation, and BMPs promote heterotopic ossification in skeletal muscles in mice.

Egerman M, Zhang Y, Donne R, Xu J, Gadi A, McEwen C Skelet Muscle. 2025; 15(1):4.

PMID: 39994804 PMC: 11853584. DOI: 10.1186/s13395-025-00373-7.


Extracellular matrix proteins refine microenvironments for pancreatic organogenesis from induced pluripotent stem cell differentiation.

Hu M, Liu T, Huang H, Ogi D, Tan Y, Ye K Theranostics. 2025; 15(6):2229-2249.

PMID: 39990212 PMC: 11840725. DOI: 10.7150/thno.104883.


Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies.

Sheikh K, Amjad M, Irfan M, Anjum S, Majeed T, Riaz M Onco Targets Ther. 2025; 18:233-262.

PMID: 39989503 PMC: 11846535. DOI: 10.2147/OTT.S493643.


References
1.
Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K . NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Biochem J. 2004; 386(Pt 3):461-70. PMC: 1134864. DOI: 10.1042/BJ20040738. View

2.
David C, Massague J . Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018; 19(7):419-435. PMC: 7457231. DOI: 10.1038/s41580-018-0007-0. View

3.
Wilkes M, Murphy S, Garamszegi N, Leof E . Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol. 2003; 23(23):8878-89. PMC: 262664. DOI: 10.1128/MCB.23.23.8878-8889.2003. View

4.
Penheiter S, Singh R, Repellin C, Wilkes M, Edens M, Howe P . Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell. 2010; 21(22):4009-19. PMC: 2982134. DOI: 10.1091/mbc.E09-12-1019. View

5.
Shi Y, Hata A, Lo R, Massague J, Pavletich N . A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 1997; 388(6637):87-93. DOI: 10.1038/40431. View